These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2989911)
1. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint. Strating A Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911 [No Abstract] [Full Text] [Related]
3. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species. McConnell S; Morrill JC; Livingston CW Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912 [TBL] [Abstract][Full Text] [Related]
4. The current status of research on an experimental inactivated bluetongue virus vaccine. Stott JL; Osburn BI; Barber TL Proc Annu Meet U S Anim Health Assoc; 1979; (83):55-62. PubMed ID: 233389 [No Abstract] [Full Text] [Related]
5. Clinical and serological response of sheep to serial challenge with different bluetongue virus types. Jeggo MH; Gumm ID; Taylor WP Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836 [TBL] [Abstract][Full Text] [Related]
6. The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine. Huismans H Onderstepoort J Vet Res; 1985 Sep; 52(3):149-51. PubMed ID: 3003649 [TBL] [Abstract][Full Text] [Related]
7. Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation. Campbell CH; Barber TL; Knudsen RC; Swaney LM Prog Clin Biol Res; 1985; 178():639-47. PubMed ID: 2989913 [TBL] [Abstract][Full Text] [Related]
8. Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus. Wark MC; Shepherd-Clark MB; Smith HV; Collins WD Aust Vet J; 1982 Jul; 59(1):6-10. PubMed ID: 6293439 [TBL] [Abstract][Full Text] [Related]
9. [Vaccination against bluetongue serotype 8 in the Netherlands]. Kuijk H; Jansen M; Moulin V; Makoschey B Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439 [No Abstract] [Full Text] [Related]
10. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189 [TBL] [Abstract][Full Text] [Related]
11. Bluetongue vaccines. Noad R; Roy P Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295 [TBL] [Abstract][Full Text] [Related]
12. Bluetongue vaccination in Europe. Zientara S; MacLachlan NJ; Calistri P; Sanchez-Vizcaino JM; Savini G Expert Rev Vaccines; 2010 Sep; 9(9):989-91. PubMed ID: 20822340 [No Abstract] [Full Text] [Related]
17. Production of murine cytotoxic T lymphocytes by bluetongue virus following various immunisation procedures. Jeggo MH; Wardley RC Res Vet Sci; 1982 Sep; 33(2):212-5. PubMed ID: 6293026 [TBL] [Abstract][Full Text] [Related]
18. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167 [No Abstract] [Full Text] [Related]
19. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy. Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459 [TBL] [Abstract][Full Text] [Related]
20. Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine. Eschbaumer M; Wäckerlin R; Hoffmann B; Beer M Vaccine; 2010 Jan; 28(4):881-2. PubMed ID: 19925907 [No Abstract] [Full Text] [Related] [Next] [New Search]